Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced Saline vs Albumin for Volume Expansion in Shock
NCT05463471Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of ringer's acetate in Shock (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Percentage of Cardiac Output Index Change at 2 hours and Percentage of Stroke Volume Index Change at 2 hours. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
ringer's acetate
03
Conditions
Shock
Beyond the preview
Go deeper on NCT05463471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05463471.